Enabling Access to Cutting-Edge Medicine Through Value-Based Contracting
Lyfegen is catalyzing the value-based care revolution by enabling the adoption of VBCs for pharmaceuticals. Value-based contracts (VBCs) are contracts between payers and manufacturers that tie drug prices to clinical success.
The Company's platform first educates transacting parties on the types of VBCs that could be appropriate for a particular drug, then provides a platform to monitor and automatically adjudicate contracts in real-time.
Lyfegen's platform collects real-world data and uses intelligent algorithms to provide valuable insights on drug performance and cost in value-based contracts.
Lyfegen is making VBCs mainstream, taking a systematic approach to positively impacting patient access to treatment and reducing the overall cost of care.